stock offering
SomaLogic to Go Public Through Merger With Special Purpose Acquisition Company
Following the transaction, which values the company at roughly $1.2 billion and will provide cash proceeds of around $650 million, SomaLogic will list on the Nasdaq.
Exagen Prices $60.1M Public Offering of Stock
The company said it plans to use the proceeds to develop multiomics capabilities, including building out its clinical laboratory.
VolitionRx Prices $20M Public Offering
VolitionRx, which develops epigenetic-based blood tests for cancer and other diseases, said it will use the proceeds of the offering for general corporate purposes.
OpGen Enters $25M Direct Offering Agreement
A single healthcare-focused investor will purchase 2.78 million shares of common stock, 5.55 million prefunded warrants, and an additional 4.17 million shares of common stock.
Oncocyte to Raise $35M in Public Stock Offering
Net proceeds from the offering will primarily support commercialization and further development of the company's DetermaRx and DetermaIO assays.